Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,768 public trials 494 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery

NCT01989572

Conditions
Eye Diseases, Eye Neoplasms, Iris Melanoma, +34 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 148 locations
View Trial Details
Completed

Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer

NCT01642251

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +23 more
Locations
  • Loma Linda University Medical Center Loma Linda, California, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • Rocky Mountain Cancer Centers-Aurora Aurora, Colorado, United States
  • The Medical Center of Aurora Aurora, Colorado, United States
View all 428 locations
View Trial Details
Completed

A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)

NCT05708950

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +76 more
Locations
  • UCLA Health (Santa Monica Cancer Care) Santa Monica, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Sarah Cannon Research Institute at Florida Cancer Specialists Sarasota, Florida, United States
  • University of Michigan Ann Arbor, Michigan, United States
View Trial Details
Completed

A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors

NCT03289962

Conditions
Bladder Cancer, Breast Diseases, Breast Neoplasms, +48 more
Locations
  • HonorHealth Research Institute ? Bisgrove Scottsdale, Arizona, United States
  • The Los Angeles Clinic Los Angeles, California, United States
  • UCSF Comprehensive Cancer Ctr San Francisco, California, United States
  • Stanford Cancer Center Stanford, California, United States
View all 33 locations
View Trial Details

Related conditions